These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

495 related items for PubMed ID: 30888262

  • 1. Gender-specific predictors of methadone treatment outcomes among African Americans at an urban clinic.
    Lister JJ, Brown S, Greenwald MK, Ledgerwood DM.
    Subst Abus; 2019; 40(2):185-193. PubMed ID: 30888262
    [Abstract] [Full Text] [Related]

  • 2. Baseline risk factors for drug use among African-American patients during first-month induction/stabilization on methadone.
    Lister JJ, Greenwald MK, Ledgerwood DM.
    J Subst Abuse Treat; 2017 Jul; 78():15-21. PubMed ID: 28554598
    [Abstract] [Full Text] [Related]

  • 3. Gender-specific predictors of retention and opioid abstinence during methadone maintenance treatment.
    Levine AR, Lundahl LH, Ledgerwood DM, Lisieski M, Rhodes GL, Greenwald MK.
    J Subst Abuse Treat; 2015 Jul; 54():37-43. PubMed ID: 25795601
    [Abstract] [Full Text] [Related]

  • 4. Injection opioid use as a predictor of treatment outcomes among methadone-maintained opioid-dependent patients.
    Ledgerwood DM, Lister JJ, LaLiberte B, Lundahl LH, Greenwald MK.
    Addict Behav; 2019 Mar; 90():191-195. PubMed ID: 30412910
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Effect of community-based extension clinics of methadone maintenance therapy for opiate-dependent clients: A prospective cohort study in Dehong Prefecture, Yunnan Province of China.
    Zhang G, Yang Y, Ye R, Zhang D, Shan D, Hu Y, Dai B, Liu Z.
    Medicine (Baltimore); 2018 Nov; 97(47):e13323. PubMed ID: 30461647
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. The real-world impact of dosing of methadone and buprenorphine in retention on opioid agonist therapies in Ukraine.
    Farnum SO, Makarenko I, Madden L, Mazhnaya A, Marcus R, Prokhorova T, Bojko MJ, Rozanova J, Dvoriak S, Islam Z, Altice FL.
    Addiction; 2021 Jan; 116(1):83-93. PubMed ID: 32428276
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Factors predicting retention in treatment: 10-year experience of a methadone maintenance treatment (MMT) clinic in Israel.
    Peles E, Schreiber S, Adelson M.
    Drug Alcohol Depend; 2006 May 20; 82(3):211-7. PubMed ID: 16219428
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Characteristics and Outcome of Male and Female Methadone Maintenance Patients: MMT in Tel Aviv and Las Vegas.
    Adelson M, Linzy S, Peles E.
    Subst Use Misuse; 2018 Jan 28; 53(2):230-238. PubMed ID: 28574738
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Gender disparities in access and retention in outpatient methadone treatment for opioid use disorder in low-income urban communities.
    Marsh JC, Amaro H, Kong Y, Khachikian T, Guerrero E.
    J Subst Abuse Treat; 2021 Aug 28; 127():108399. PubMed ID: 34134873
    [Abstract] [Full Text] [Related]

  • 20. Opioid use following the introduction of an extended-release oxycodone formulation with tamper-resistant properties: Prospective historical chart review in methadone-maintained patients.
    Sankey C, Setnik B, Harsanyi Z, Michalko K, Yang Z, Geoffroy P.
    J Opioid Manag; 2016 Aug 28; 12(2):149-59. PubMed ID: 27194200
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 25.